These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4387512)

  • 1. [A new per os drug in ORL pathology F.F. 65].
    Terrail
    Rev Corps Sante Armees Terre Mer Air; 1967 Oct; 8(5):691-703. PubMed ID: 4387512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical testing with F.F.65 at the E.N.T clinic of the medical faculty of Bordeaux].
    Flandrin JC
    J Med Bord; 1967 Aug; 144(8):1181-8. PubMed ID: 4390384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of a peroral association in otorhinolaryngological pathology].
    Mounier-Kuhn P; Bouchayer M; Bernard P; Dumolard P
    Rev Lyon Med; 1967 Nov; 16(17):717-20. PubMed ID: 4393694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptomatic treatment of ORL diseases in children with an antihistaminic-decongestant-analgesic combination].
    Bebear JP
    Rev Laryngol Otol Rhinol (Bord); 1975; 96(1-2):90-2. PubMed ID: 49912
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with dexchlorpheniramine in ortorhinolaryngology.
    Haines HL
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):568-70. PubMed ID: 4378757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of allergic manifestations in otorhinolaryngology by the antihistaminic Tavegyl].
    Mitrović M; Stojković M
    Srp Arh Celok Lek; 1969 Jun; 97(6):661-6. PubMed ID: 4392416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical, rhinorheometric and sonomanometric study of the effects of F.F. 65 in rhinosinusal and tubal pathology].
    Riu R; Le Den R; Le Mouel C; Martin JC
    Rev Corps Sante Armees Terre Mer Air; 1968 Jun; 9(3):365-76. PubMed ID: 4102910
    [No Abstract]   [Full Text] [Related]  

  • 8. [HS 592 (Tavegil) in the treatment of allergic manifestations in otorhinolaryngoiatry. Clinical contribution].
    Biscaro G
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1969; 80(4):285-95. PubMed ID: 4394333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Record of the utilization in otorhinolaryngology of an anticongestive, anti-inflammatory and analgesic combination effective by oral route (180 clinical cases)].
    Mounier-Kuhn P; Fontvieille J
    Sem Ther; 1968 Oct; 44(8):451-9. PubMed ID: 4391711
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihistamines in otolaryngology.
    Silcox LE
    Trans Pa Acad Ophthalmol Otolaryngol; 1968; 21(2):74-80. PubMed ID: 4388425
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic effect of a new antisecretory and anti-acid drug].
    Galli L; Bissi A
    Rev Bras Gastroenterol; 1967; 19(3):43-9. PubMed ID: 4387428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic note: the use of Alphamucase per os in ORL pathology].
    Mounier-Kuhn P; Haguenauer JP; Charachon R
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1967 Jan; 16(1):43-7. PubMed ID: 4229647
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of ulcer with a new antacid-antisecretive-antispastic combination].
    Castellazzi V; Marenco G; Ghibaudi D
    Clin Ter; 1969 Apr; 49(1):47-61. PubMed ID: 4396961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and radiographical study on the effects of the treatment of peptic ulcer with a new antacid-antiulcer agent].
    Piro E; Florio F; Tripodi R
    Clin Ter; 1970 May; 53(4):323-48. PubMed ID: 4394193
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of corticosteroids and antihistaminics in otorhinolaryngology].
    Davidzon MI
    Med Sestra; 1969 Jun; 28(6):8-11. PubMed ID: 4389626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effect of a new antisecretory and antacid medication].
    Galli L; Bissi A
    Minerva Chir; 1968 May; 23(9):477-82. PubMed ID: 4386093
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of an antihistamine administered in delayed action form: dimegan].
    Mounier-Kuhn P; Haguenauer JP
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1968 May; 17(5):456-7. PubMed ID: 4386661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Several antihistaminic pharmacodynamic aspects, especially of Eprozinol].
    Duchene-Marullaz P; Rispat G; Perriere JP
    Therapie; 1971; 26(1):155-62. PubMed ID: 4396627
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peroral combination preparations in acute illnesses].
    Naess K
    Tidsskr Nor Laegeforen; 1969 Sep; 89(18):1433-4. PubMed ID: 4393270
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of anti-motion sickness drugs by body responses to labyrinthine stimulation.
    Sugano H; Tominaga H
    Agressologie; 1977; 18 Spec No():63-7. PubMed ID: 19980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.